According to Fact.MR’s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period (2017-2026). Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026-e. With continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for dual chamber prefilled syringes manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section. Dual chamber prefilled syringes have evolved to the stage where they are functionally useful for the packaging of lyophilized small volume parental drugs.
Over the past decade, several companies have started to focus on approaches such as life-cycle management in order to improve the competitiveness of their existing products. This can be credited to the rising stringency of regulatory parameters along with reduction in the number of novel and guaranteed successful drugs in biopharmaceutical and pharmaceutical pipelines.
A CAGR of 8.7% has been projected for the global dual chamber prefilled syringes market during the forecast period, 2017 to 2026, according to a new study of Fact.MR. Roughly US$ 3,300 Mn worth of dual chamber prefilled syringes are likely to be sold across the globe by 2026-end.
For More Details - A sample of this report is available upon request here -
https://www.factmr.com/connectus/sample?flag=S&rep_id=486
Owing to the existence of vast number of parenteral drugs, custom drug delivery devices with prefilled syringes are imperative. As such, companies look to offer exhaustive portfolio of high-quality products and adapt the syringe system to the customer’s individual requirements profile. Accordingly, use of prefilled syringes in parental drugs is enjoying an increase in popularity.
The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of global dual chamber prefilled syringes market. The global market for dual chamber prefilled syringes has been segmented into sales channel, product type, product material, and region. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.
Prefilled syringes have gained popularity owing to enhanced user safety, ease of use and the decline of potential dosage errors. At-home administration, self-administration and the surge of biologics are the primary aspects that trigger the growth of dual chamber prefilled syringes market. On account of low cost and adoption of self-administered drugs, conventional prefilled syringes are expected to be most preferred products in the market. Meanwhile, prefilled has become integral part of auto-injection segment of the drug delivery market, which needs prefilled cartridges.
Dual chamber prefilled syringes have garnered attention of customers as prefilling pays off in saved bulk substance as vials applied for standard injections have to be overfilled. Besides, sealing the containers leverages for ingenious and new packaging methods and exact tracking systems to avert tampering, mix-ups and mistakes that could jeopardize the integrity of a drug between patients and filing line. Sales of dual chamber prefilled syringes are expected to record the fastest expansion in online pharmacies through 2026, trailed by retail pharmacies that will account for a relatively larger market revenue share than online pharmacies by 2026-end. In terms of revenues, hospital pharmacies will continue to be the leading contributor to the global dual chamber prefilled syringes market. Based on product material, glass prefilled syringes are anticipated to remain sought-after in the market, with sales projected to exceed US$ 2,000 Mn in revenues by 2026-end. Plastic prefilled syringes will exhibit a relatively higher CAGR in the market through 2026.
Dual Chamber Prefilled Syringes Market: Overview
The report provides a comprehensive assessment on the dual chamber prefilled syringes market with quantitative and qualitative analysis. Further, the report offers a clear picture with respect to dynamics of dual chamber prefilled syringes market, including drivers, trends, opportunities, and restraints. These aspects are indispensable and possess potency to impact the growth of the dual chamber prefilled syringes market. Besides, the report delves into the segregation of the dual chamber prefilled syringes market to provide a robust picture of dual chamber prefilled syringes market.
Competitive Landscape
Some players in the market are also focusing on making improvements in design of dual chamber prefilled syringes for improving stability and safety of sensitive drugs. Fact.MR’s report has listed key players augmenting the market expansion, which include Bespak Europe Ltd, Catalent, Inc., Credence MedSystems, Inc., Otsuka America Pharmaceutical, Inc., Schott AG, West Pharmaceutical Services, Inc., Ypsomed Holding AG, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG, Nipro Corporation, Boehringer Ingelheim GmbH, Amgen Inc., and Pfizer Inc.
Have Any Query?? Ask Our Industry Expert
https://www.factmr.com/connectus/sample?flag=AE&rep_id=486
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
sales@factmr.com
www.factmr.com
